Rucaparib is a medication used in the treatment of ovarian cancer, particularly for patients with BRCA mutations. It is a poly(ADP-ribose) polymerase (PARP) inhibitor that interferes with DNA repair mechanisms in cancer cells, leading to their death. Rucaparib is used in patients with advanced ovarian cancer who have already undergone chemotherapy.
Cleanchem is a trusted provider of premium pharmaceutical reference materials, specializing in Rucaparib and its associated compounds. Our catalog includes pharmacopeial and non-pharmacopeial Rucaparib impurities, metabolites, nitrosamine derivatives (N-NO compounds), and stable isotope-labeled products. These reference standards play a critical role in pharmaceutical R&D, supporting activities such as product formulation, ANDA and DMF submissions, quality assurance, analytical method development, and stability assessments.
All Rucaparib-related substances undergo comprehensive characterization and are delivered with complete Certificates of Analysis and supporting analytical documentation to ensure regulatory adherence. Upon request, we can offer EP/USP traceable standards. Our products are routinely re-evaluated to maintain consistent quality and performance.
English
Arabic
Chinese (Simplified)
French
Japanese
Portuguese
Russian
Spanish
